Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

BRNSABUS

Barinthus Biotherapeutics plc

BRNS · $0.74

52Fair

Arbutus Biopharma Corp

ABUS · $4.20

78Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

BRNS

52/100

ABUS

78/100

Quality

Is it a profitable, well-run business?

BRNS

2.0/10

ABUS

10.0/10

Growth

Is the company growing?

BRNS

0.1/10

ABUS

8.0/10

Valuation

Is the price reasonable? (higher = cheaper)

BRNS

6.7/10

ABUS

7.5/10

Risk

How risky are the shares? (higher = lower risk)

BRNS

4.2/10

ABUS

7.3/10

Momentum

Is the share price trending up?

BRNS

6.5/10

ABUS

5.5/10

Financial strength

Is the balance sheet healthy?

BRNS

3.9/10

ABUS

9.0/10

The balanced view

Model-generated

Barinthus Biotherapeutics plc

This company has a mixed profile, with supportive analyst views and a reasonable valuation, although its growth has been slow.

Leads on: momentum

Best feature: analysts broadly positive (Target upside: 305.4%)

Watch out: growth is slow or negative (Revenue growth (FY): -100.0%)

Arbutus Biopharma Corp

This company scores well across most areas, with strong profitability and supportive analyst views.

Leads on: quality, growth, valuation, risk, financial strength

Best feature: strong profitability (Return on equity (TTM): 91.0%)

Watch out: weakest area: price momentum (Signal consensus: Strong Sell)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.